Emphysema is diagnosed through a combination of breathing tests, CT imaging, and clinical evaluation. The single most important test is spirometry, which measures how much air you can force out of your lungs and how quickly. A specific ratio on that test, taken after inhaling a bronchodilator medication, is the standard threshold for confirming the diagnosis. But spirometry alone doesn’t tell the full story, and most people go through several steps before getting a clear picture of what’s happening in their lungs.
Spirometry: The Core Diagnostic Test
Spirometry is the first test your doctor will order if emphysema is suspected. You blow into a mouthpiece as hard and fast as you can, and the device measures two key numbers: how much air you can exhale in one second (called FEV1) and the total volume of air you can force out in one full breath (called FVC). The ratio between these two numbers is what clinches the diagnosis.
According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), the diagnostic threshold is an FEV1/FVC ratio below 0.7 after using a bronchodilator. The bronchodilator part matters. In asthma, inhaling a bronchodilator opens the airways significantly and the ratio often returns to normal. In emphysema, the obstruction barely budges. That persistent, largely irreversible airflow limitation is what separates emphysema from asthma on a breathing test. Roughly 10% of people with COPD do show some reversibility, but even in those cases the improvement is modest compared to what you’d see in asthma.
Your FEV1 value also helps stage severity. The lower the number relative to what’s predicted for your age, height, and sex, the more advanced the disease.
What a Physical Exam Reveals
Before any tests are ordered, a physical exam can raise strong suspicion. The hallmark of emphysema is that it takes longer to push air out than to pull it in. A simple bedside check called forced expiratory time captures this: if it takes you longer than 6 seconds to fully exhale, that indicates severe airflow obstruction.
Other physical findings include a barrel-shaped chest, where the front-to-back diameter of the ribcage increases to roughly twice normal. Tapping on the chest produces a hollow, hyperresonant sound because the lungs are overinflated with trapped air. Breath sounds are quieter than normal when listened to with a stethoscope, and you may hear scattered wheezing. As the disease progresses, your breathing rate climbs, and you start using neck and shoulder muscles to help pull air in. In advanced stages, doctors may notice muscle wasting in the arms and legs, a bluish tint to the skin, swollen ankles, or bulging neck veins, all signs that the heart is straining under the load of damaged lungs.
CT Scans: The Most Accurate Imaging Tool
A standard chest X-ray can show signs of overinflated lungs, but it misses mild emphysema entirely. CT scanning is far more sensitive. On a CT image, emphysema appears as scattered dark areas of abnormally low density in the lung tissue, either without surrounding walls or with walls thinner than 1 millimeter. These dark patches represent destroyed air sacs that have merged into larger, useless spaces.
Research published in CHEST found that CT correlates with the actual extent of emphysema tissue damage at a level of 0.91 on a 0-to-1 scale, making it the most accurate way to diagnose emphysema in a living person. CT can detect emphysema even when chest X-rays and breathing tests look normal, which is particularly useful in early disease. Higher-resolution scans using thinner image slices (1.5 mm instead of 10 mm) improve accuracy further. That said, CT isn’t perfect. In studies comparing scans to tissue samples, a small number of people with mild disease were missed.
CT also helps identify the pattern of destruction. Centrilobular emphysema, the type most closely linked to smoking, starts in the upper portions of the lungs. Panacinar emphysema, more common in people with a genetic deficiency, tends to affect the lower lungs evenly. Knowing the pattern can guide both diagnosis and treatment planning.
Gas Transfer Testing
Spirometry tells you how well air moves in and out. A different test, called a diffusing capacity test (DLCO), measures how efficiently oxygen crosses from your lungs into your bloodstream. You breathe in a small, harmless amount of carbon monoxide, hold it briefly, then exhale. The amount absorbed reflects how much healthy surface area remains in your lungs.
Normal results fall between 75% and 140% of the predicted value. A mildly reduced DLCO, between 60% and 75%, suggests some loss of gas-exchanging tissue. Values below 40% indicate severe destruction. This test is especially useful for distinguishing emphysema from chronic bronchitis, the other main form of COPD. In chronic bronchitis, the airways are inflamed and clogged with mucus but the air sacs themselves are relatively intact, so DLCO often stays closer to normal. In emphysema, the air sacs are destroyed, and DLCO drops.
How Emphysema Is Distinguished From Asthma
Both conditions cause shortness of breath and wheezing, so telling them apart matters. The key differences show up in several ways. Asthma involves variable obstruction that comes and goes, often triggered by allergens or exercise, and responds well to bronchodilators and inhaled steroids. Emphysema produces steady, progressive obstruction that worsens over years and responds poorly to the same medications.
The underlying biology is also different. Asthma is driven primarily by eosinophils and mast cells, which cause the airways to tighten and swell. Emphysema is driven by neutrophils and macrophages, which release enzymes that physically break down the walls of the air sacs. Asthma affects the larger airways without damaging the lung tissue itself. Emphysema targets the smallest airways and the delicate air sac walls, permanently destroying them. This distinction is why asthma, even when severe, doesn’t produce the same kind of irreversible tissue loss seen on CT in emphysema.
The Six-Minute Walk Test
This deceptively simple test measures how far you can walk on a flat surface in six minutes. It captures something spirometry can’t: how your lungs actually perform during real-world physical activity. A study in the European Respiratory Journal tracked people with severe COPD and found that every additional 50 meters walked reduced the risk of death by 18%. People who walked less than 100 meters had significantly worse survival than those who covered more than 300 meters.
The test is also used to track disease progression over time. A declining walk distance signals worsening lung function and can prompt changes in treatment or referral for procedures like lung volume reduction.
Genetic Testing for Alpha-1 Antitrypsin Deficiency
About 1 in 25 people of European descent carries a gene variant that reduces levels of a protective protein called alpha-1 antitrypsin. This protein normally shields lung tissue from damage by neutralizing the enzymes that white blood cells release during routine immune activity. Without enough of it, those enzymes chew through air sac walls unchecked, causing emphysema that can appear as early as your 30s or 40s, especially in smokers.
Current guidelines from the COPD Foundation recommend that all individuals diagnosed with COPD be tested for this deficiency, regardless of age or ethnicity. The test is a simple blood draw. Identifying the deficiency matters because it opens the door to a specific treatment (infusions of the missing protein) and because it has implications for family members who may carry the same gene variant without knowing it.
Putting the Pieces Together
No single test diagnoses emphysema on its own. Spirometry confirms airflow obstruction. The bronchodilator response helps rule out asthma. CT imaging shows the physical destruction and its pattern. DLCO quantifies how much gas-exchanging tissue remains. The walk test gauges real-world impact. And a blood test screens for the genetic form of the disease. Most people won’t need every one of these tests, but if your spirometry is abnormal and your symptoms fit, expect your doctor to move through several of them to pin down exactly what’s going on and how far it’s progressed.